{"text": "hoth 2 2 biolexa topical agent is in development for the following indications atopic dermatitis eczema aesthetic dermatology surgical site infections chronic diabetic woundcare azn nvax bmy mrk"}
{"text": "paul torres cohen bmy"}
{"text": "bristol withdraws istodax lymphoma indication after confirmatory trial fails bmy"}
{"text": "bristol withdraws istodax lymphoma indication after confirmatory trial fails bmy"}
{"text": "bmy bristol withdraws istodax lymphoma indication after confirmatory trial fails"}
{"text": "disciplined investments llc has filed form 13f for q2 2021 opened new positions in adp aes amt bmy ciu csx dfac dfae dfai dfat try insider forms mobile app get realtime notifications and more"}
